POLYPLUS
LIVE

Serial Number

79292615

Owner

POLYPLUS TRANSFECTION

Attorney

Pina Campagna

Filing Date

May 6, 2020

Add to watchlist:

No watchlists yet
View on USPTO

POLYPLUS Trademark

Serial Number: 79292615 • Registration: 6413661

POLYPLUS is a trademark filed by POLYPLUS TRANSFECTION on May 6, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

POLYPLUS TRANSFECTION (23 trademarks)

75 rue Marguerite Perey

Entity Type: 99

Sartorius Polyplus (14 trademarks)

75 rue Marguerite Perey

Entity Type: 98

Trademark Details

Filing Date

May 6, 2020

Registration Date

July 13, 2021

Published for Opposition

April 27, 2021

Goods & Services

Chemicals and biochemical for medical and clinical use, namely, chemical and biochemical preparations for genetic diseases; chemicals and biochemical for medical and clinical use in the field of genetics, namely, chemical and biochemical preparations for transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-virus particles for genetic diseases; chemical preparations for medical use for research and for genetic diagnostics, namely, for genetic diseases; diagnostic agents for medical use for research and for genetic diagnostics; reagents for medical use for research and for genetic diagnostics; chemical and biochemical diagnostic reagent test kits for medical and clinical use comprised of medical diagnostic preparations, agents and reagents for use in disease testing; diagnostic assay kits and chemical and biochemical diagnostic test kits, all for medical and clinical use in the field of genetics, comprised of preparations, agents and reagents for transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and producing transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-virus particles, for use in disease testing; pharmaceutical products for the treatment of genetic diseases; medicines for the treatment of genetic diseases; medical and veterinary diagnostic preparations; sanitary products for medical purposes, namely, sanitary preparations for medical use

Retail and wholesale store services, including online, of transfection agents, products, agents and reagents for scientific and clinical research, in particular in the field of genetics

Chemical and biochemical analyses; genetic analyses for scientific research purposes; structural and functional analysis of genomes; analyses in the field of molecular biology; scientific analyses and research in the field of transfection; software design, computer software design in the field of scientific research and genetic analyses; consulting in relation to research and development of transfections agents and agents, reagents and chemicals and biochemical used in the field of genetics; development of pharmaceutical products; scientific development of transfection agents; development of new products in the field of gene therapy; computer-aided scientific testing of DNA samples for diagnostic purposes; laboratory research in the field of genetics; conducting clinical trials for others for pharmaceutical and genetic products; scientific research in the field of medicines; scientific research in the field of genetics and genetic engineering; scientific research for medical purposes in the field of genetics and genetic engineering; services of a genetic research laboratory, namely, genetic testing for scientific research purposes and development of gene therapies for medical purposes; research and development of new products for third parties; scientific testing services in the field of genetics

Chemical and biochemical products in the nature of preparations for scientific use and for research, other than for medical or veterinary use; chemical and biochemical products in the nature of preparations for scientific use and for research in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-viral particles, other than for medical or veterinary use; chemical preparations, agents and reagents for scientific use and for scientific research for genetic diagnosis; chemical and biochemical test kits for scientific laboratory use and for research use containing preparations, agents and reagents, for life science research, virus, protein, antibody production and in vivo injection; chemical and biochemical test kits for scientific laboratory use and for research use containing preparations, agents and reagents in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production of transfected cells, cell lines, recombinant proteins, peptides, antibodies, viruses and/or pseudo-viral particles

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 1, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Dec 11, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 30, 2025 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 31, 2021 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 26, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 9, 2021 FICS
FINAL DISPOSITION PROCESSED
Nov 9, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 13, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 13, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 27, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Apr 25, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 7, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 7, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 7, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2021 TROA
REFUSAL PROCESSED BY IB
Oct 4, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 11, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 11, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 10, 2020 RFCR
NON-FINAL ACTION WRITTEN
Sep 9, 2020 CNRT
REFUSAL PROCESSED BY MPU
Sep 3, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 2, 2020 RFCR
NON-FINAL ACTION WRITTEN
Sep 1, 2020 CNRT
NON-FINAL ACTION WRITTEN
Sep 1, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 1, 2020 MAFR
ASSIGNED TO EXAMINER
Aug 28, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 28, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 27, 2020 REPR